Whang-Peng J - Search Results

1

Elevation of interleukin-10 levels in malignant pleural effusion.

Chen YM, Yang WK, Whang-Peng J, Kuo BI, Perng RP. Chen YM, et al. Chest. 1996 Aug;110(2):433-6. doi: 10.1378/chest.110.2.433. Chest. 1996. PMID: 8697847

2

Induced Pluripotent Stem Cell-conditioned Medium Suppressed Melanoma Tumorigenicity Through the Enhancement of Natural-Killer Cellular Immunity.

Hsieh CT, Luo YH, Chien CS, Wu CH, Tseng PC, Chiou SH, Lee YC, Whang-Peng J, Chen YM. Hsieh CT, et al. J Immunother. 2016 May;39(4):153-9. doi: 10.1097/CJI.0000000000000117. J Immunother. 2016. PMID: 27023059

3

Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes.

Chang GC, Liu KJ, Hsieh CL, Hu TS, Charoenfuprasert S, Liu HK, Luh KT, Hsu LH, Wu CW, Ting CC, Chen CY, Chen KC, Yang TY, Chou TY, Wang WH, Whang-Peng J, Shih NY. Chang GC, et al. Clin Cancer Res. 2006 Oct 1;12(19):5746-54. doi: 10.1158/1078-0432.CCR-06-0324. Clin Cancer Res. 2006. PMID: 17020980

4

A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma.

Chang GC, Lan HC, Juang SH, Wu YC, Lee HC, Hung YM, Yang HY, Whang-Peng J, Liu KJ. Chang GC, et al. Cancer. 2005 Feb 15;103(4):763-71. doi: 10.1002/cncr.20843. Cancer. 2005. PMID: 15637694 Free article.

5

PD-L1 Expression of Tumor Cells, Macrophages, and Immune Cells in Non-Small Cell Lung Cancer Patients with Malignant Pleural Effusion.

Tseng YH, Ho HL, Lai CR, Luo YH, Tseng YC, Whang-Peng J, Lin YH, Chou TY, Chen YM. Tseng YH, et al. J Thorac Oncol. 2018 Mar;13(3):447-453. doi: 10.1016/j.jtho.2017.10.034. Epub 2017 Dec 12. J Thorac Oncol. 2018. PMID: 29246835 Free article.

6

Chromosomal aberrations of malignant pleural effusions of lung adenocarcinoma: different cytogenetic changes are correlated with genders and smoking habits.

Yen CC, Liang SC, Jong YJ, Chen YJ, Lin CH, Chen YM, Wu YC, Su WC, Huang CY, Tseng SW, Whang-Peng J. Yen CC, et al. Lung Cancer. 2007 Sep;57(3):292-301. doi: 10.1016/j.lungcan.2007.04.007. Epub 2007 Jun 5. Lung Cancer. 2007. PMID: 17553591

7

A randomized trial of different docetaxel schedules in non-small cell lung cancer patients who failed previous platinum-based chemotherapy.

Chen YM, Shih JF, Perng RP, Tsai CM, Whang-Peng J. Chen YM, et al. Chest. 2006 Apr;129(4):1031-8. doi: 10.1378/chest.129.4.1031. Chest. 2006. PMID: 16608954 Clinical Trial.

8

Chemotherapy for non-small cell lung cancer in elderly patients.

Chen YM, Perng RP, Shih JF, Tsai CM, Whang-Peng J. Chen YM, et al. Chest. 2005 Jul;128(1):132-9. doi: 10.1378/chest.128.1.132. Chest. 2005. PMID: 16002926

9

Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A*0201 and HLA-A*2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides.

Liu KJ, Wang CC, Chen LT, Cheng AL, Lin DT, Wu YC, Yu WL, Hung YM, Yang HY, Juang SH, Whang-Peng J. Liu KJ, et al. Clin Cancer Res. 2004 Apr 15;10(8):2645-51. doi: 10.1158/1078-0432.ccr-03-0430. Clin Cancer Res. 2004. PMID: 15102666 Clinical Trial.

10

Double signal stimulation was required for full recovery of the autologous tumor-killing effect of effusion-associated lymphocytes.

Chen YM, Tsai CM, Whang-Peng J, Perng RP. Chen YM, et al. Chest. 2002 Oct;122(4):1421-7. doi: 10.1378/chest.122.4.1421. Chest. 2002. PMID: 12377874

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results